Profil
Jin Yin Wang served as an Executive Chairman at Standard Chartered Corporate Advisory Co., Ltd. He also worked as an Associate at Lehman Brothers Asia Ltd. (Hong Kong) in 2007-2008.
In 2020-2023, he was a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd. Mr. Wang holds an undergraduate degree and a graduate degree from the University of International Business & Economics, and an MBA from the Stephen M.
Ross School of Business.
Anciens postes connus de Jin Yin Wang
| Sociétés | Poste | Fin |
|---|---|---|
| JW (CAYMAN) THERAPEUTICS CO. LTD | Directeur/Membre du Conseil | 29/08/2023 |
Lehman Brothers Asia Ltd. (Hong Kong)
Lehman Brothers Asia Ltd. (Hong Kong) Investment Banks/BrokersFinance Engages in purchase, sale and brokerage of securities | Corporate Officer/Principal | 01/09/2008 |
Standard Chartered Corporate Advisory Co., Ltd. | Président | - |
Formation de Jin Yin Wang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of International Business & Economics
University of International Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehman Brothers Asia Ltd. (Hong Kong)
Lehman Brothers Asia Ltd. (Hong Kong) Investment Banks/BrokersFinance Engages in purchase, sale and brokerage of securities | Finance |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Standard Chartered Corporate Advisory Co., Ltd. | |
JW (Cayman) Therapeutics Co. Ltd.
JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
















